Corbus Pharmaceuticals Holdings, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $7.0M | $50.6M | $48.9M |
| Jun 2017 | $7.0M | $44.6M | $43.0M |
| Sep 2017 | $6.4M | $38.4M | $36.6M |
| Dec 2017 | $9.2M | $67.0M | $62.5M |
| Mar 2018 | $11.6M | $77.1M | $71.0M |
| Jun 2018 | $14.8M | $70.3M | $64.7M |
| Sep 2018 | $18.3M | $61.2M | $55.7M |
| Dec 2018 | $19.5M | $47.0M | $41.7M |
| Mar 2019 | $59.1M | $101.4M | $89.9M |
| Jun 2019 | $36.7M | $84.1M | $73.2M |
| Sep 2019 | $38.5M | $68.1M | $54.8M |
| Dec 2019 | $43.0M | $49.1M | $31.7M |
| Mar 2020 | $42.5M | $65.2M | $46.6M |
| Jun 2020 | $49.7M | $98.1M | $63.5M |
| Sep 2020 | $66.6M | $95.8M | $81.9M |
| Dec 2020 | $57.0M | $102.3M | $85.4M |
| Mar 2021 | $48.6M | $140.1M | $66.6M |
| Jun 2021 | $43.6M | $120.6M | $36.1M |
| Sep 2021 | $41.9M | $119.6M | $37.1M |
| Dec 2021 | $38.6M | $107.7M | $25.0M |
| Mar 2022 | $34.5M | $95.7M | $57.0M |
| Jun 2022 | $32.6M | $82.1M | $25.8M |
| Sep 2022 | $31.9M | $73.8M | $12.4M |
| Dec 2022 | $33.3M | $66.3M | $17.0M |
| Mar 2023 | $35.2M | $51.6M | $7.3M |
| Jun 2023 | $34.2M | $43.7M | $8.3M |
| Sep 2023 | $36.0M | $36.3M | $11.2M |
| Dec 2023 | $35.2M | $28.3M | $13.7M |
| Mar 2024 | $28.8M | $125.7M | $14.1M |
| Jun 2024 | $26.4M | $152.0M | $23.7M |
| Sep 2024 | $13.7M | $164.2M | $19.4M |
| Dec 2024 | $13.5M | $155.9M | $17.2M |
| Mar 2025 | $12.8M | $139.9M | $18.9M |
| Jun 2025 | $14.1M | $125.1M | $20.0M |
| Sep 2025 | $17.4M | $109.5M | $27.0M |
| Dec 2025 | $20.7M | $168.2M | $28.5M |
| Mar 2026 | $18.1M | $144.5M | $25.7M |
| Jun 2026 | $24.7M | $127.0M | $23.4M |